Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Aug 1;182(2):581-6.
doi: 10.1084/jem.182.2.581.

Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords

Affiliations

Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords

J G Cyster et al. J Exp Med. .

Abstract

The normal migration route of B cells into follicular areas of spleen and lymph nodes is altered in the case of autoreactive cells that have bound self-antigen. To begin characterizing the molecular requirements for B cell migration into follicles, cells were treated with pertussis toxin (PTX), an inhibitor of signaling by many G protein-coupled chemokine receptors. Lymphocyte accumulation in the spleen is not inhibited by PTX and, therefore, the distribution of transferred cells was examined in this tissue. In contrast to untreated cells that localized predominantly in follicular areas within white pulp cords, PTX-treated B cells failed to enter white pulp areas altogether and accumulated in the splenic red pulp. T cells were also excluded from white pulp cords and in the case of both cell types, the adenosine diphosphate-ribosylating subunit of the toxin was required to block white pulp entry. These findings implicate a G protein-coupled receptor in lymphocyte migration into splenic white pulp cords. Exclusion of PTX-treated cells from all organized areas of secondary lymphoid tissues raises the possibility that the association observed between PTX treatment and predisposition to autoimmune disease results from inhibition of tolerance mechanisms that normally operate within secondary lymphoid tissues.

PubMed Disclaimer

References

    1. Int Immunol. 1992 Feb;4(2):163-75 - PubMed
    1. Int Rev Cytol. 1992;132:31-74 - PubMed
    1. J Exp Med. 1993 Jun 1;177(6):1821-6 - PubMed
    1. J Exp Med. 1993 Jul 1;178(1):367-72 - PubMed
    1. Annu Rev Immunol. 1994;12:593-633 - PubMed

Publication types

Substances